Results 271 to 280 of about 59,250 (306)

Thyroid Nodules and Differentiated Thyroid Cancer

2014
The incidence of thyroid nodules and thyroid cancer has increased over the last several decades. This change is influenced by several factors, to include the status of iodine sufficiency, access to the health care system and, perhaps most significantly, the increased use of radiological imaging.
openaire   +2 more sources

The evolution of differentiated thyroid cancer

Pathology, 2017
Differentiated thyroid tumours of follicular cell derivation have traditionally been classified based on architecture, cytology, or both. The features that distinguish the various entities are controversial and diagnostic criteria are inconsistent and often irreproducible. The complexity of classification schemes has not been substantiated by molecular
openaire   +2 more sources

Differentiated thyroid cancer – 2009

Orvosi Hetilap, 2011
Three years ago continental guidelines were published referring management and follow-up of low risk thyroid cancer patients. The aim of this paper is to summarize the changes and new directions in this field. High risk patients require another protocol. Neck ultrasound plays important role in differential diagnosis and in detecting recurrences.
openaire   +2 more sources

Update on Differentiated Thyroid Cancer Staging

Endocrinology and Metabolism Clinics of North America, 2014
In this review, we demonstrate how initial estimates of the risk of disease-specific mortality and recurrent/persistent disease should be used to guide initial treatment recommendations and early management decisions and to set appropriate patient expectations with regard to likely outcomes after initial therapy of thyroid cancer.
Denise P, Momesso, R Michael, Tuttle
openaire   +2 more sources

The therapeutic management of differentiated thyroid cancer

Expert Opinion on Pharmacotherapy, 2008
The management of thyroid cancer is difficult because the tumors comprise a wide range of biologic behaviors, from small papillary thyroid microcarcinomas that pose little or no threat to survival for the patient, to anaplastic thyroid cancers that are arguably the most lethal tumor.
Jennifer A, Sipos, Ernest L, Mazzaferri
openaire   +2 more sources

[Differentiated thyroid cancer].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 1991
In the interval 1979-1988, out of 1070 operated goiters 77 malignant thyroid tumors were recorded, 60 of them being differentiated: papillary--32 (53.4%), vesicular--12 (20%), mixed forms--16 (26.7%). The differentiated thyroid carcinomas had peculiar clinical biological and prognostic features and were framed: stage I--60%, stage II--23.4% and state ...
M, Chifan, V, Strat, E, Tîrcoveanu, D, Niculescu, M, Bordea, S, Georgescu, E, Zbranca, G, Dobrescu, N, Florea, T, Baran   +9 more
openaire   +1 more source

[Differentiated thyroid cancer].

Der Internist, 2015
Thyroid carcinoma is a rare and heterogeneous disease. Initial therapy and follow-up has to be adjusted to the individual risk for an excellent vs. poor prognosis. Differentiated thyroid cancer has a very high cure rate and is treated by surgery, usually followed by radioiodine ablation.
V, Tiedje, K W, Schmid, F, Weber, A, Bockisch, D, Führer   +4 more
openaire   +1 more source

Differentiated Thyroid Cancer

2005
Thyroid nodules are relatively common in adult women but uncommon in adult men and in children and adolescents, and children are infrequently affected by differentiated thyroid cancer. When this cancer does occur in a child, the patient’s prognosis is generally favorable and he or she can expect a near-normal life span; however, it can prove to be a ...
openaire   +1 more source

Differentiated thyroid cancer and pregnancy

Nuclear Medicine Communications, 2000
T B, O'Connell, M J, O'Doherty
openaire   +2 more sources

Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer

Endocrine Practice, 2021
Max A Schumm, Melissa G Lechner, Jiyoon Kim   +2 more
exaly